Deciphera Pharmaceuticals Inc.

NAS: DCPH

GO
/marketstate/country/us

Market open

/zigman2/quotes/203556943/composite

$

33.85

Change

-0.05 -0.13%

Volume

Volume 79,894

Oct 27, 2021, 12:55 p.m.

Real time quotes

/zigman2/quotes/203556943/composite

Previous close

$ 33.89

$ 33.85

Change

-0.05 -0.13%

Day low

Day high

$33.57

$34.16

Open
Open: 33.78

52 week low

52 week high

$26.20

$68.40

Open

Market cap

$1.97B

Average volume

361,570

P/E ratio

N/A

Rev. per Employee

$120,249

EPS

-4.50

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/dcph

MarketWatch News on DCPH

  1. Deciphera Pharmaceuticals stock price target cut to $65 from $84 at Truist

    7:16 a.m. Oct. 4, 2021

    - Tomi Kilgore

  2. Deciphera Pharmaceuticals coverage resumed at Stifel with buy stock rating and $60 target price

    7:05 a.m. Sept. 30, 2021

    - Tonya Garcia

  3. Deciphera Pharmaceuticals started at buy with $75 stock price target at Stifel Nicolaus

    10:16 a.m. Dec. 3, 2020

    - Tomi Kilgore

  4. Callon, Fitbit, Genco Shipping, and Other 13D Filings

    10:30 p.m. Nov. 22, 2019

    - Barron's Online

  5. Deciphera Pharmaceuticals stock price target raised to $60 from $45 at SunTrust RH

    8:40 a.m. Aug. 14, 2019

    - Tomi Kilgore

  6. Deciphera Pharmaceuticals stock rockets 126% premarket after positive trial data for GIST treatment

    8:32 a.m. Aug. 13, 2019

    - Tomi Kilgore

  7. Deciphera Pharmaceuticals started at buy with $42 stock price target at Deutsche Bank

    2:17 p.m. July 18, 2019

    - Tomi Kilgore

  8. Deciphera Pharmaceuticals started at outperform with $47 stock price target at Raymond James

    8:25 a.m. Aug. 29, 2018

    - Tomi Kilgore

  9. Deciphera Pharmaceuticals started at buy with $60 stock price target at SunTrust RH

    7:54 a.m. July 5, 2018

    - Tomi Kilgore

  10. Deciphera Pharmaceuticals started at overweight with $30 stock price target at J.P. Morgan

    7:40 a.m. Oct. 23, 2017

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/dcph

Other News on DCPH

  1. 3 Biotech Stocks With Huge Catalysts Incoming

    6:13 a.m. Oct. 22, 2021

    - Motley Fool

  2. Deciphera (DCPH) Thrives on Qinlock, Overdependence a Woe

    10:08 a.m. Oct. 15, 2021

    - Zacks.com

  3. A Trio of Stocks Growing Capex Fast

    11:53 a.m. Oct. 12, 2021

    - GuruFocus.com

  4. Loading more headlines...
/news/pressrelease/company/us/dcph

Press Releases on DCPH

  1. Deciphera Pharmaceuticals, Inc. to Host Earnings Call

    2:30 p.m. May 4, 2021

    - ACCESSWIRE

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.